PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Title only   |   Print    Next page > 
     
HistoIndex Extends Access To Its MASH Diagnostic Offering Through New Partnerships In Texas And California
SINGAPORE , April 28, 2026 /PRNewswire/ -- HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced the continued expansion of its commercial partnership ...
2026-04-28T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
Australian company unlocks a new era for women's health globally with an innovative delivery system for Female testosterone in women with low libido
Massive unmet need for Hypoactive Sexual Desire Disorder treatments addressed by new Female Testosterone product Phase I and II clinical trials completed. Phase III to be done in co-development with ...
2026-04-28T    Health Care/Hospital   Medical/Pharmaceuticals 
Introduced the first 'Bhutan International Travel Mart (BITM)' 2026 and launched the website www.bitm.bt
The Bhutan International Travel Mart (BITM) will be held for the first time in Bhutan from 11th to 13th June 2026 at Zhichenkhar, Thimphu. The BITM website, a central information hub for buyers, exhibitors, ...
2026-04-28T    Banking/Financial Service   Fashion   Food/Beverages   Health Care/Hospital 
BLINDED ASSESSMENT OF ACTION3 STATISTICAL ASSUMPTIONS COMPLETE
Key Highlights: ...
2026-04-28T    Health Care/Hospital   Medical/Pharmaceuticals 
Cordis Launches SELUTION SLR™ PTA Drug-Eluting Balloon (DEB) in Japan
TOKYO , April 28, 2026 /PRNewswire/ -- Cordis, a global leader in interventional cardiovascular technologies, today announces the launch and availability of the SELUTION SLR™ PTA Drug-Eluting Balloon ...
2026-04-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach
MELBOURNE, Australia and INDIANAPOLIS , April 28, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") announces an educational webinar exploring the evolution ...
2026-04-28T    Health Care/Hospital   Medical/Pharmaceuticals 
Cellenkos, Inc. Announces FDA Clearance to Initiate Phase 2 Clinical Trial of CK0801 (Allogeneic Cord Blood-Derived Tregs) for Aplastic Anemia
Phase 2 multicenter, open-label study (NCT07499102) will evaluate the safety and clinical efficacy of CK0801 Tregs in transfusion-dependent aplastic anemia. ...
2026-04-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
The EXCEL - First-of-its-kind study highlights critical role of essential phospholipids in improving Fatty Liver Disease
PARIS , April 27, 2026 /PRNewswire/ -- A new study has established that treatment with essential phospholipids (Essentiale) resulted in a 2.5 times greater reduction in liver fat, significant improvement ...
2026-04-27T    Health Care/Hospital   Medical/Pharmaceuticals 
CONCEPT MEDICAL ANNOUNCES PRELIMINARY 3-YEAR SIRONA DATA AT CHARING CROSS SYMPOSIUM 2026
LONDON , April 27, 2026 /PRNewswire/ -- Concept Medical Inc. , today announced the presentation of preliminary 3-year follow-up data from the SIRONA randomised trial at the Charing Cross (CX) Symposium ...
2026-04-27T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Asia's Top Dairy Yili Sweeps Awards at GDIC Asia 2026
SINGAPORE , April 27, 2026 /PRNewswire/ -- From April 22 to 23, the 9th Global Dairy Innovation Congress (GDIC) Asia 2026 took place in Singapore. Dr. Ignatius Szeto, Vice President of Yili Group, Asia's ...
2026-04-27T    Beverages   Food/Beverages   Health Care/Hospital 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.